Detailed FISH Analysis of HER2 2+Immunohistochemistry Cases: Rarity of Cases with High Level HER2 Gene Amplification

被引：0
|
作者：
Gingell, D. C. [1 ]
Dabbs, D. J. [1 ]
Surti, U. [1 ]
Bhargava, R. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
179
引用
收藏
页码：42A / 42A
页数：1
相关论文
共 50 条
  • [41] HER2 gene mutations in non-small cell lung carcinomas: Concurrence with her2 gene amplification and her2 protein expression and phosphorylation
    Suzuki, Mikiko
    Shiraishi, Kouya
    Yoshida, Akihiko
    Shirnada, Yoko
    Suzuki, Kenji
    Asamura, Hisao
    Furuta, Koh
    Kohno, Takashi
    Tsuta, Koji
    LUNG CANCER, 2015, 87 (01) : 14 - 22
  • [42] In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases
    Silvia Giuliani
    Chiara Maura Ciniselli
    Elena Leonardi
    Enzo Polla
    Nicola Decarli
    Claudio Luchini
    Chiara Cantaloni
    Fabio Gasperetti
    Daniela Cazzolli
    Gabriella Berlanda
    Daniela Bernardi
    Marco Pellegrini
    Renza Triolo
    Antonella Ferro
    Paolo Verderio
    Mattia Barbareschi
    Virchows Archiv, 2016, 469 : 45 - 50
  • [43] HER2 FISH Testing with RAI1 Alternate Probe Will Resolve HER2 Status in Majority of Equivocal Cases
    Hui, Ling
    Geiersbach, Katherine
    Downs-Kelly, Erinn
    Factor, Rachel E.
    Gulbahce, H. Evin
    LABORATORY INVESTIGATION, 2016, 96 : 46A - 46A
  • [44] HER2 FISH Testing with RAI1 Alternate Probe Will Resolve HER2 Status in Majority of Equivocal Cases
    Hui, Ling
    Geiersbach, Katherine
    Downs-Kelly, Ennn
    Factor, Rachel E.
    Gulbahce, H. Evin
    MODERN PATHOLOGY, 2016, 29 : 46A - 46A
  • [45] In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+and HER2 2+/Her2 amplified cases
    Giuliani, Silvia
    Ciniselli, Chiara Maura
    Leonardi, Elena
    Polla, Enzo
    Decarli, Nicola
    Luchini, Claudio
    Cantaloni, Chiara
    Gasperetti, Fabio
    Cazzolli, Daniela
    Berlanda, Gabriella
    Bernardi, Daniela
    Pellegrini, Marco
    Triolo, Renza
    Ferro, Antonella
    Verderio, Paolo
    Barbareschi, Mattia
    VIRCHOWS ARCHIV, 2016, 469 (01) : 45 - 50
  • [46] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [47] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [48] Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma
    Sukov, William R.
    Zhou, Jain
    Geiersbach, Katherine B.
    Keeney, Gary L.
    Carter, Jodi M.
    Schoolmeester, J. Kenneth
    HUMAN PATHOLOGY, 2023, 137 : 94 - 101
  • [49] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    Cancer Cell International, 22
  • [50] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
12345